Chávez-López DD, Méndez-Bacca I, Poletti-Vázquez ED

Language: Spanish
References: 19
Page: 25-29
PDF size: 219.23 Kb.

ABSTRACT

We present the case of a 16-year-old female patient, with a diagnosis of phakomatosis pigmentovascularis (PPV) cesioflammea type IIb (Sturge-Weber syndrome and nevus of Ota). She was treated with two laser modalities for the cutaneous components (pulsed dye laser and PicoWay laser). Her evolution was acceptable after several sessions, however, the long-term prognosis of PPV depends on extracutaneous manifestations.

REFERENCES

1. Happle R, Phacomatosis pigmentovascularis revisited and reclassified, Arch Dermatol 2005; 141:385-8.

2. Vidaurri de la Cruz H, Tamayo-Sánchez L, Duran-McKinster C, Orozco- Covarrubias M de L y Ruiz-Maldonado R, Phakomatosis pigmentovascularis II A and II B: clinical fin dings in 24 patients, J Dermatol 2003; 30:381-8.

3. Viada-Peláez MC, Stefano PC, Cirio A y Cervini AB, Facomatosis pigmentovascular tipo cesioflammea: a propósito de un caso, Arch Argent Pediatr 2018; 116(1):e121-e124.

4. Cadavid M, Zapata F y Velásquez N, Facomatosis pigmentovascularis asociada a síndrome de Klippel-Trenaunay y a alopecia triangular. Reporte de caso, Rev ces Medicina 2012; 26(2):229-36.

5. Adachi K, Togashi S, Sasaki K y Sekido M, Laser therapy treatment of phacomatosis pigmentovascularis type II: two case reports, J Med Case Rep 2013; 27(7):55.

6. Namiki T, Takahashi M, Nojima K, Ueno M, Hanafusa T, Tokoro S y Yokozeki H, Phakomatosis pigmentovascularis type IIb: a case with Klippel–Trenaunay syndrome and extensive dermal melanocytosis as nevus of Ota, nevus of Ito and ectopic Mongolian spots, J Dermatol 2017; 44(3):e32-e3.

7. Goyal T y Varshney A. Phacomatosis cesioflammea: first case report from India, Indian J Dermatol Venereol Leprol 2010; 76(3):307.

8. Cordisco M, Campo A, Castro C et al., Phakomatosis pigmentovascularis: report of 25 cases, Ped Dermatol 2001; 18(Sup70):65.

9. Fernández-Guarino, Boixeda P, De las Heras E et al., Phakomatosis pigmento vascularis: clinical fidings in 15 patients and review of the literature, J Am Acad Dermatol 2008; 58(1):88-93.

10. Thomas A, Zeng Z, Rivière JB et al., Mosaic activating mutations in gna11 and gnaq are associated with phakomatosis pigmentovascularis and extensive dermal melanocytosis, J Invest Dermatol 2016; 136(4):770-8.

11. Kono T, Erçöçen AR, Chan HH, Kikuchi Y et al., Treatment of phacomatosis pigmento vascularis: a combined multiple laser approach, Dermatol Surg 2003; 29(6):642-6.

12. Segatto MM, Schmitt E, Hagemann L et al., Phacomatosis pigmentovascularis type IIa: case report, An Bras Dermatol 2013; 88(6 Suppl 1):S85-8.

13. Jerdan K, Hsu JT y Schnurstein E, Successful treatment of Ota nevus with the 532-nm solid-state picosecond laser, Cutis, 2017; 99(3):E29-E31.

14. Ohshiro T, Sasaki K y Kishi K, Picosecond pulse duration laser treatment for dermal melanocytosis in Asians: a retrospective review, Laser Ther 2016; 29(2):99-104.

15. Torrelo A, Zambrano A y Happle R, Cutis marmorata telangiectatica congenita and extensive mongolian spots: type 5 phacomatosis pigmentovascularis, Br J Dermatol 2003; 148:342-5.

16. Habbema L, Verhagen R, Van Hal R et al., Minimally invasive non-thermal laser technology using laser induced optical breakdown for skin rejuvenation, J Biophotonics 2012; 5(2):194-9.

17. Bernstein E, Schomacker K, Paranjape A et al., Treatment of photoaging with a dual-wavelength, 532 nm and 1 064 nm picosecond-domain laser producing a fractionated treatment beam using a holographic optic, J Drugs in Dermatol 2017; 16(11):611-6.

18. Bernstein E, Schomacker K y Basilavecchio L, Treatment of acne scarring with a novel fractionated, dual-wavelength, picosecond-domain laser incorporating a novel holographic beam-splitter, Lasers in Surgery and Medicine 2017; 49:796-802.

19. Yu W, Zhu J, Yu X, Lyu D, Lin X y Zhang Z, A split-face, single-blinded, randomized controlled comparison of alexandrite 755-nm picosecond laser versus alexandrite 755-nm nanosecond laser in the treatment of acquired bilateral nevus of Ota elike macules, J Am Acad Dermatol 2018; 79:479-86.